• Dolen, G., Osterweil, E., Rao, B.S., Smith, G.B., Auerbach, B.D., Chattarji, S., et al. (2007). Correction of fragile X syndrome in mice. Neuron, 56, 955962.
  • Gordon, C.T., State, R.C., Nelson, J.E., Hamburger, S.D., & Rapoport, J.L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry, 50, 441447.
  • Kanner, L. (1943). Autistic disturbances of affective contact. The Nervous Child, 2, 217250.
  • King, B.H., Hollander, E., Sikich, L., McCracken, J.T., Scahill, L., Bregman, J.D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives Gen Psychiatry, 66, 583590.
  • McDougle, C.J., Naylor, S.T., Cohen, D.J., Volkmar, F.R., Heninger, G.R., & Price, L.H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry, 53, 10011008.
  • Nakatani, J., Tamada, K., Hatanaka, F., Ise, S., Ohta, H., Inoue, K., et al. (2009). Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell, 137, 12351246.
  • Owley, T., Walton, L., Salt, J., Guter, S.J., Winnega, M., Leventhal, B.L., et al. (2005). An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry, 44, 343348.